Clinicopathological characteristics and MYC status determine treatment outcome in plasmablastic lymphoma: a multi-center study of 76 consecutive patients.
Hanno M WitteNadine HertelHartmut MerzHeinz-Wolfram BerndVeronica BernardStephanie StöltingNikolas von BubnoffAlfred C FellerNiklas GebauerPublished in: Blood cancer journal (2020)